| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.5 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |